Skip to content

Clinical trials

Retinitis Pigmentosa trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20151
20181
20191
20201
20211
20233
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed3
Unknown status3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhongshan Ophthalmic Center, Sun Yat-sen University3
Sun Yat-sen University2
Chigenovo Co., Ltd1
Eye & ENT Hospital of Fudan University1
Eyecure Therapeutics Inc.1
National Eye Institute (NEI)1
Peking University Third Hospital1
Qi Zhou1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1
Suzhou UgeneX Therapeutics Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa15
Diabetic Retinopathy2
Retinal Diseases2
Cataract1
Central Serous Chorioretinopathy1
Epiretinal Membrane1
Glaucoma1
Leber Congenital Amaurosis1
Macular Degeneration1
Ocular Hypertension1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.